Oxaloacetate Restores HIF ‐1α‐Mediated Mitochondrial Homeostasis to Counter Tubulointerstitial Injury in Diabetic Kidney Disease
Authors:
- 3 March 2026
- journal article
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 28 (5) , 4216-4231
Abstract
Background: Renal tubular injury, one of the most critical events in diabetic kidney disease (DKD), plays a pivotal role in the progression of the disease. Metabolic reprogramming of renal tubular cells emerges as a prominent pathological feature, yet its underlying molecular mechanisms remain incompletely understood. Methods: We established a streptozotocin‐induced mouse model of diabetes. Metabolomic analysis was then used to characterise DKD‐specific metabolic alterations. To test the functional consequence of a metabolic intervention, DKD mice received intraperitoneal injections of oxaloacetate (OAA). Furthermore, molecular docking and cellular thermal shift assays were used to elucidate the molecular mechanisms underlying OAA's effects on renal tubular injury, which were further validated in HK‐2 cells exposed to high glucose. Finally, a specific pharmacological inhibitor was applied to study the relevant signalling pathway. Results: Metabolomic profiling identified a marked decrease in OAA, a key tricarboxylic acid (TCA) cycle intermediate, in injured renal tubular cells. OAA supplementation significantly attenuated tubulointerstitial injury, as evidenced by reduced tubular cell damage, fibrosis, and macrophage infiltration. Moreover, restored mitochondrial homeostasis was observed in DKD mice after OAA treatment. Mechanistically, we found that OAA inhibited prolyl hydroxylase domain 2 (PHD2), an essential regulator of hypoxia‐inducible factor‐1α (HIF‐1α), thereby stabilising mitochondrial homeostasis. Furthermore, pharmacological inhibition of HIF‐1α abolished the protective effects of OAA, confirming the involvement of the PHD2/HIF‐1α axis. Conclusions: OAA ameliorates renal tubulointerstitial injury in DKD by restoring mitochondrial homeostasis through the PHD2/HIF‐1α axis.Keywords
Funding Information
- Natural Science Foundation of Jiangsu Province (BK20240212)
- Natural Science Foundation of Jiangsu Province (BK20240297)
- Natural Science Foundation of Shandong Province (ZR2022MH161)
- Qingdao Key Health Discipline Development Fund
This publication has 58 references indexed in Scilit:
- Isoquercitrin Alleviates Diabetic Nephropathy by Inhibiting STAT3 Phosphorylation and DimerizationAdvanced Science, 2025
- Hypoxia‐Preconditioned BMSC‐Derived Exosomes Induce Mitophagy via the BNIP3–ANAX2 Axis to Alleviate Intervertebral Disc DegenerationAdvanced Science, 2024
- ACSF2 and lysine lactylation contribute to renal tubule injury in diabetesDiabetologia, 2024
- Tubular TMEM16A promotes tubulointerstitial fibrosis by suppressing PGC-1α-mediated mitochondrial homeostasis in diabetic kidney diseaseCellular and Molecular Life Sciences, 2023
- Pharmacological inhibition of BAP1 recruits HERC2 to competitively dissociate BRCA1–BARD1, suppresses DNA repair and sensitizes CRC to radiotherapyActa Pharmaceutica Sinica B, 2023
- KIM-1 mediates fatty acid uptake by renal tubular cells to promote progressive diabetic kidney diseaseCell Metabolism, 2021
- Hypoxia and hypoxia-inducible factors in diabetes and its complicationsDiabetologia, 2021
- Oxaloacetate induces apoptosis in HepG2 cells via inhibition of glycolysisCancer Medicine, 2018
- A Map of Protein-Metabolite Interactions Reveals Principles of Chemical CommunicationCell, 2018
- Nutrient-Sensitive Mitochondrial NAD+ Levels Dictate Cell SurvivalCell, 2007